Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Regional Scope
1.1.2 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.2 Variable analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective - 1
1.10.2 Objective - 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 REGION
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage outlook
3.1.1 Parent market outlook
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Rise in the number of initiatives to promote contraceptive methods
3.3.1.2 Increasing number of unwanted pregnancies
3.3.2 Market restraint analysis
3.3.2.1 Rapidly aging population and rising prevalence of infertility
3.3.2.2 Lack of awareness and adverse effects of contraceptive implants
3.4 Business Environment Analysis Tools
3.4.1 Porter’s five forces analysis
3.4.2 PESTEL analysis
3.5 Major Deals & Strategic Alliances Analysis
3.6 Pipeline Analysis
Chapter 4 Contraceptive Implants Market: Regional Analysis
4.1 Contraceptive Implants Regional Market Share Analysis, 2018 & 2026
4.2 Contraceptive Implants Regional Market: Segment Dashboard
4.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
4.4 Market Size, Forecasts, and Trend Analysis, 2015 to 2026
4.4.1 North America
4.4.1.1 North America contraceptive implants market, 2015 - 2026 (USD Million)
4.4.1.2 U.S.
4.4.1.2.1 Regulatory and reimbursement scenario
4.4.1.2.2 U.S. contraceptive implants market, 2015 - 2026 (USD Million)
4.4.1.3 Canada
4.4.1.3.1 Regulatory and reimbursement scenario
4.4.1.3.2 Canada contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2 Europe
4.4.2.1 Europe contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2.2 Germany
4.4.2.2.1 Regulatory and reimbursement scenario
4.4.2.2.2 Germany contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2.3 U.K.
4.4.2.3.1 Regulatory and reimbursement scenario
4.4.2.3.2 U.K. contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2.4 France
4.4.2.4.1 Regulatory and reimbursement scenario
4.4.2.4.2 France contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2.5 Italy
4.4.2.5.1 Regulatory and reimbursement scenario
4.4.2.5.2 Italy contraceptive implants market, 2015 - 2026 (USD Million)
4.4.2.6 Spain
4.4.2.6.1 Regulatory and reimbursement scenario
4.4.2.6.2 Spain contraceptive implants market, 2015 - 2026 (USD Million)
4.4.3 Asia Pacific
4.4.3.1 Asia Pacific contraceptive implants market, 2015 - 2026 (USD Million)
4.4.3.2 Japan
4.4.3.2.1 Regulatory and reimbursement scenario
4.4.3.2.2 Japan contraceptive implants market, 2015 - 2026 (USD Million)
4.4.3.3 China
4.4.3.3.1 Regulatory and reimbursement scenario
4.4.3.3.2 China contraceptive implants market, 2015 - 2026 (USD Million)
4.4.3.4 India
4.4.3.4.1 Regulatory and reimbursement scenario
4.4.3.4.2 India contraceptive implants market, 2015 - 2026 (USD Million)
4.4.4 Latin America
4.4.4.1 Latin America contraceptive implants market, 2015 - 2026 (USD Million)
4.4.4.2 Brazil
4.4.4.2.1 Regulatory and reimbursement scenario
4.4.4.2.2 Brazil contraceptive implants market, 2015 - 2026 (USD Million)
4.4.4.3 Mexico
4.4.4.3.1 Regulatory and reimbursement scenario
4.4.4.3.2 Mexico contraceptive implants market, 2015 - 2026 (USD Million)
4.4.5 Middle East and Africa
4.4.5.1 MEA contraceptive implants market, 2015 - 2026 (USD Million)
4.4.5.2 South Africa
4.4.5.2.1 Regulatory and reimbursement scenario
4.4.5.2.2 South Africa contraceptive implants market, 2015 - 2026 (USD Million)
Chapter 5 Competitive Analysis
5.1 Recent developments & impact analysis, by key market participants
5.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
5.2.1 Strategy Mapping
5.3 Public and Private Companies
5.3.1 Company market position analysis (Overall market presence, geographic presence, product portfolio, and Strategic Initiatives)
5.4 Supplier/Distributor Shipment Data
5.4.1 Top 10 FP2020 Countries in terms of contraceptives supplier-shipment values, 2017
5.5 Company Profiles
5.5.1 Bayer AG
5.5.1.1 Company overview
5.5.1.2 Financial performance
5.5.1.3 Product benchmarking
5.5.1.4 Strategic initiatives
5.5.1.5 SWOT analysis
5.5.2 Merck & Co., Inc.
5.5.2.1 Company overview
5.5.2.2 Financial performance
5.5.2.3 Product benchmarking
5.5.2.4 Strategic initiative
5.5.2.5 SWOT analysis
5.5.3 Shanghai Dahua Pharmaceutical Co., Ltd.
5.5.3.1 Company overview
5.5.3.2 Product benchmarking
5.5.3.3 Strategic initiatives
5.5.3.4 SWOT analysis
Chapter 6 KoL Commentary
6.1 KoL Commentary
List of Tables
TABLE 1 List of secondary sources
TABLE 2 List of abbreviation
TABLE 3 Characteristics of different subdermal contraceptive implants
TABLE 4 Supply chain contraceptive shipment details
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market outlook
Fig. 9 Contraceptive implants market segmentation
Fig. 10 Market trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter's five forces analysis
Fig. 14 PESTEL analysis
Fig. 15 Subdermal contraceptive implants regional market share analysis, 2018 & 2026
Fig. 16 Subdermal contraceptive implants regional market: Segment dashboard
Fig. 17 Regional marketplace: Key takeaways
Fig. 18 North America subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 19 U.S. subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 20 Canada subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 21 Europe subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 22 Germany subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 23 U.K. subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 24 France subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 25 Italy subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 26 Spain subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 27 Asia Pacific subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 28 China subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 29 India subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 30 Japan subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 31 Latin America subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 32 Brazil subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 33 Mexico subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 34 MEA subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 35 South Africa subdermal contraceptive implants market, 2015 - 2026 (USD Million)
Fig. 36 Recent developments
Fig. 37 Strategy framework
Fig. 38 Strategy mapping
Fig. 39 Company market position analysis ( Market presence, geographical presence, product portfolio, & strategic initiatives)
Fig. 40 Top 10 FP2020 countries in terms of contraceptives supplier-shipment values, 2017
Fig. 41 KoL commentary